Target intelligence / Profile preview

Dermatan sulfate epimerase pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The **dermatan sulfate epimerase pseudogene** (LOC347097, ENSG00000224025) is a non-protein-coding segment of DNA that resembles the functional dermatan sulfate epimerase (DSE) gene[1]. Pseudogenes are generally considered nonfunctional relics of gene evolution but may in some cases regulate gene expression through RNA interference or acting as microRNA decoys[2][5]. There is no evidence that this pseudogene encodes a functional protein, acts as an enzyme, receptor, transporter, or canonical therapeutic target. No known role in disease, clinical biomarker utility, or drug interaction is associated with LOC347097. The functional DSE gene encodes an enzyme involved in dermatan sulfate biosynthesis and is associated with Ehlers-Danlos syndrome (musculocontractural type), but this does not apply to the pseudogene[3][4][6]. Summary of core issues: LOC347097 is a pseudogene, not a functional protein or receptor. It is not a therapeutic target and does not encode a druggable protein[1][2]. It is sometimes incorrectly listed as a target due to confusion with its functional paralog, the DSE gene. If seeking information about dermatan sulfate epimerase as a drug target, focus on the functional DSE gene, not this pseudogene[3][4][6].

Other names
LOC347097ENSG00000224025
02

Biological functions

Possible regulation of related coding gene expression via noncoding RNA or microRNA decoy activity (general property of some pseudogenes)[2][5]
03

Disease associations

Other (Emerging evidence suggests pseudogene-derived RNAs may be deregulated in cancer, but no disease role is described for LOC347097 itself)[2][5]

Beyond the preview

Go deeper on Dermatan sulfate epimerase pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermatan sulfate epimerase pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call